SPOT Spotify Technology | $699.13
-1.8% | 6/6/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | Low | View details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 6/6/2025 |
RBRK Rubrik | $93.27
-4.7% | 6/6/2025 | Target Raised by | Guggenheim | Analyst John Difucci | Buy -> Buy | $105.00 -> $108.00 | Low | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 6/6/2025 |
SNY Sanofi | $49.75
-1.4% | 6/3/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | Low | View details for Guggenheim rating of Sanofi (NASDAQ:SNY) on 6/3/2025 |
VERA Vera Therapeutics | $22.19
-2.2% | 6/3/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | High | View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 6/3/2025 |
BPMC Blueprint Medicines | $127.97
+0.1% | 6/3/2025 | Target Set by | Guggenheim | Analyst M. Schmidt | | $132.00 | Low | View details for Guggenheim rating of Blueprint Medicines (NASDAQ:BPMC) on 6/3/2025 |
KYMR Kymera Therapeutics | $47.16
-1.0% | 6/3/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $60.00 | Medium | View details for Guggenheim rating of Kymera Therapeutics (NASDAQ:KYMR) on 6/3/2025 |
DLTR Dollar Tree | $93.85
-0.7% | 6/5/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $100.00 | Low | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 6/5/2025 |
ORCL Oracle | $177.19
+1.8% | 6/5/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $220.00 | Low | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 6/5/2025 |
MDB MongoDB | $217.23
-1.3% | 6/5/2025 | Target Raised by | Guggenheim | Analyst H. Ma | Buy -> Buy | $235.00 -> $260.00 | High | View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 6/5/2025 |
BPMC Blueprint Medicines | $127.97
+0.1% | 6/3/2025 | Downgraded by | Guggenheim | Analyst M. Schmidt | Strong-Buy -> Hold | | Low | View details for Guggenheim rating of Blueprint Medicines (NASDAQ:BPMC) on 6/3/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
APTV Aptiv | $67.20
+0.8% | 6/4/2025 | Downgraded by | Guggenheim | Analyst Ali Faghri | Buy -> Neutral | | Low | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 6/4/2025 |
EOSE Eos Energy Enterprises | $4.18
+8.9% | 6/2/2025 | Target Lowered by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $7.00 -> $6.00 | Low | View details for Guggenheim rating of Eos Energy Enterprises (NASDAQ:EOSE) on 6/2/2025 |
NYT New York Times | $55.67
-0.3% | 6/2/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Neutral -> Neutral | $53.00 -> $55.00 | Low | View details for Guggenheim rating of New York Times (NYSE:NYT) on 6/2/2025 |
REGN Regeneron Pharmaceuticals | $517.60
+4.9% | 5/30/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | High | View details for Guggenheim rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 5/30/2025 |
BBY Best Buy | $72.75
-0.4% | 5/30/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $90.00 | Low | View details for Guggenheim rating of Best Buy (NYSE:BBY) on 5/30/2025 |
ESTC Elastic | $85.82
-0.7% | 5/30/2025 | Target Lowered by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $136.00 -> $107.00 | Medium | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 5/30/2025 |
ZS Zscaler | $299.90
-1.0% | 5/30/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | High | View details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 5/30/2025 |
ANAB AnaptysBio | $23.19
-2.2% | 5/28/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $54.00 -> $90.00 | High | View details for Guggenheim rating of AnaptysBio (NASDAQ:ANAB) on 5/28/2025 |
AZO AutoZone | $3,692.96
-0.7% | 5/28/2025 | Target Raised by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $3,850.00 -> $4,100.00 | Medium | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 5/28/2025 |
MDB MongoDB | $217.23
-1.3% | 5/28/2025 | Target Lowered by | Guggenheim | Analyst H. Ma | Buy -> Buy | $300.00 -> $235.00 | Low | View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 5/28/2025 |
RBRK Rubrik | $93.27
-4.7% | 5/28/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $80.00 -> $105.00 | Low | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 5/28/2025 |
OKTA Okta | $101.20
-3.7% | 5/28/2025 | Target Lowered by | Guggenheim | Analyst John Difucci | Buy -> Buy | $140.00 -> $138.00 | High | View details for Guggenheim rating of Okta (NASDAQ:OKTA) on 5/28/2025 |
SVRA Savara | $2.38
-2.5% | 5/28/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $9.00 -> $8.00 | High | View details for Guggenheim rating of Savara (NASDAQ:SVRA) on 5/28/2025 |
TGT Target | $97.36
+0.0% | 5/27/2025 | Target Lowered by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $155.00 -> $115.00 | Low | View details for Guggenheim rating of Target (NYSE:TGT) on 5/27/2025 |
LLY Eli Lilly and Company | $773.59
+0.5% | 5/23/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | Medium | View details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 5/23/2025 |
VIGL Vigil Neuroscience | $7.88
| 5/22/2025 | Downgraded by | Guggenheim | Analyst Y. Suneja | Strong-Buy -> Hold | | N/A | View details for Guggenheim rating of Vigil Neuroscience (NASDAQ:VIGL) on 5/22/2025 |
URGN UroGen Pharma | $7.02
-4.7% | 5/23/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $40.00 -> $15.00 | Medium | View details for Guggenheim rating of UroGen Pharma (NASDAQ:URGN) on 5/23/2025 |
WDAY Workday | $252.90
+0.1% | 5/23/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Neutral -> Neutral | | High | View details for Guggenheim rating of Workday (NASDAQ:WDAY) on 5/23/2025 |
CI The Cigna Group | $311.33
-0.3% | 5/23/2025 | Reiterated by | Guggenheim | Analyst J. Cassorla | Buy -> Buy | $388.00 | Medium | View details for Guggenheim rating of The Cigna Group (NYSE:CI) on 5/23/2025 |
VIGL Vigil Neuroscience | $7.88
| 5/22/2025 | Target Set by | Guggenheim | Analyst Yatin Suneja | Buy -> Neutral | $8.00 | Low | View details for Guggenheim rating of Vigil Neuroscience (NASDAQ:VIGL) on 5/22/2025 |
OTLK Outlook Therapeutics | $1.90
| 5/20/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | High | View details for Guggenheim rating of Outlook Therapeutics (NASDAQ:OTLK) on 5/20/2025 |
PANW Palo Alto Networks | $196.33
-1.6% | 5/21/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Sell -> Sell | $130.00 -> $130.00 | High | View details for Guggenheim rating of Palo Alto Networks (NASDAQ:PANW) on 5/21/2025 |
S SentinelOne | $18.12
-1.3% | 5/21/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $28.00 -> $28.00 | High | View details for Guggenheim rating of SentinelOne (NYSE:S) on 5/21/2025 |
HD Home Depot | $365.20
-0.6% | 5/21/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $450.00 -> $450.00 | Medium | View details for Guggenheim rating of Home Depot (NYSE:HD) on 5/21/2025 |
OKTA Okta | $101.20
-3.7% | 5/20/2025 | Reiterated by | Guggenheim | Analyst John DiFucci | Buy -> Buy | $130.00 -> $140.00 | Low | View details for Guggenheim rating of Okta (NASDAQ:OKTA) on 5/20/2025 |
AMGN Amgen | $289.98
-0.1% | 5/20/2025 | Initiated by | Guggenheim | Analyst Vamil Divan | Neutral | $288.00 | Low | View details for Guggenheim rating of Amgen (NASDAQ:AMGN) on 5/20/2025 |
TENX Tenax Therapeutics | $5.86
-3.3% | 5/15/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | $15.00 | High | View details for Guggenheim rating of Tenax Therapeutics (NASDAQ:TENX) on 5/15/2025 |
NWSA News | $27.76
-0.2% | 5/15/2025 | Reiterated by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $45.00 | High | View details for Guggenheim rating of News (NASDAQ:NWSA) on 5/15/2025 |
SBGI Sinclair | $13.39
+1.7% | 5/15/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | Medium | View details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 5/15/2025 |
DPZ Domino's Pizza | $467.95
-0.1% | 5/15/2025 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | Low | View details for Guggenheim rating of Domino’s Pizza (NASDAQ:DPZ) on 5/15/2025 |
Why Elon put $51 million into this (Ad) Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists [See The Details Here] |
ERAS Erasca | $1.63
+1.9% | 5/14/2025 | Target Set by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $3.00 | High | View details for Guggenheim rating of Erasca (NASDAQ:ERAS) on 5/14/2025 |
MLYS Mineralys Therapeutics | $16.19
+0.4% | 5/14/2025 | Target Set by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | $48.00 | Medium | View details for Guggenheim rating of Mineralys Therapeutics (NASDAQ:MLYS) on 5/14/2025 |
EXEL Exelixis | $42.92
-0.3% | 5/15/2025 | Target Set by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $45.00 | Low | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 5/15/2025 |
MRSN Mersana Therapeutics | $0.39
+1.3% | 5/16/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $5.00 -> $5.00 | High | View details for Guggenheim rating of Mersana Therapeutics (NASDAQ:MRSN) on 5/16/2025 |
CDTX Cidara Therapeutics | $25.38
+0.6% | 5/16/2025 | Target Raised by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | $35.00 -> $50.00 | High | View details for Guggenheim rating of Cidara Therapeutics (NASDAQ:CDTX) on 5/16/2025 |
ARRY Array Technologies | $7.49
-0.1% | 5/16/2025 | Target Raised by | Guggenheim | Analyst J. Osha | Buy -> Buy | $10.00 -> $12.00 | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 5/16/2025 |
GLOB Globant | $100.20
-0.7% | 5/16/2025 | Target Lowered by | Guggenheim | Analyst Jonathan Lee | Buy -> Buy | $150.00 -> $125.00 | High | View details for Guggenheim rating of Globant (NYSE:GLOB) on 5/16/2025 |
CABA Cabaletta Bio | $2.37
-4.4% | 5/15/2025 | Target Raised by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $23.00 -> $25.00 | High | View details for Guggenheim rating of Cabaletta Bio (NASDAQ:CABA) on 5/15/2025 |
PSNL Personalis | $5.40
+3.6% | 5/15/2025 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $6.00 | Low | View details for Guggenheim rating of Personalis (NASDAQ:PSNL) on 5/15/2025 |
NEO NeoGenomics | $7.56
+1.9% | 5/15/2025 | Initiated by | Guggenheim | Analyst S. Nambi | Neutral | | High | View details for Guggenheim rating of NeoGenomics (NASDAQ:NEO) on 5/15/2025 |
WGS GeneDx | $72.42
+0.5% | 5/15/2025 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $88.00 | High | View details for Guggenheim rating of GeneDx (NASDAQ:WGS) on 5/15/2025 |
WEN Wendy's | $11.46
-2.0% | 5/14/2025 | Downgraded by | Guggenheim | Analyst G. Francfort | Buy -> Neutral | | Low | View details for Guggenheim rating of Wendy’s (NASDAQ:WEN) on 5/14/2025 |
NXT Nextracker | $59.02
+0.2% | 5/14/2025 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | | High | View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 5/14/2025 |
GPI Group 1 Automotive | $431.26
+2.0% | 5/14/2025 | Downgraded by | Guggenheim | Analyst R. Jewsikow | Buy -> Neutral | | High | View details for Guggenheim rating of Group 1 Automotive (NYSE:GPI) on 5/14/2025 |
PRKS United Parks & Resorts | $42.81
-0.1% | 5/13/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $72.00 -> $74.00 | Medium | View details for Guggenheim rating of United Parks & Resorts (NYSE:PRKS) on 5/13/2025 |
TGNA TEGNA | $16.56
+0.9% | 5/13/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $20.00 -> $22.00 | Low | View details for Guggenheim rating of TEGNA (NYSE:TGNA) on 5/13/2025 |
NRG NRG Energy | $155.07
-0.6% | 5/13/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $138.00 -> $173.00 | Low | View details for Guggenheim rating of NRG Energy (NYSE:NRG) on 5/13/2025 |
DAVA Endava | $16.64
+1.0% | 5/13/2025 | Target Lowered by | Guggenheim | Analyst Jonathan Lee | Buy -> Buy | $40.00 -> $28.00 | Medium | View details for Guggenheim rating of Endava (NYSE:DAVA) on 5/13/2025 |
PLNT Planet Fitness | $102.60
-2.8% | 5/12/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $110.00 -> $110.00 | Low | View details for Guggenheim rating of Planet Fitness (NYSE:PLNT) on 5/12/2025 |
DXC DXC Technology | $15.61
-1.0% | 5/12/2025 | Reiterated by | Guggenheim | Analyst Jonathan Lee | Neutral -> Neutral | | Low | View details for Guggenheim rating of DXC Technology (NYSE:DXC) on 5/12/2025 |
XPOF Xponential Fitness | $9.34
-1.6% | 5/12/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $13.00 -> $13.00 | High | View details for Guggenheim rating of Xponential Fitness (NYSE:XPOF) on 5/12/2025 |
SWTX SpringWorks Therapeutics | $46.75
-0.1% | 5/12/2025 | Reiterated by | Guggenheim | Analyst M. Schmidt | Neutral -> Neutral | $47.00 -> $47.00 | Low | View details for Guggenheim rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 5/12/2025 |
USFD US Foods | $76.94
-1.0% | 5/12/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $80.00 -> $80.00 | Low | View details for Guggenheim rating of US Foods (NYSE:USFD) on 5/12/2025 |
ANIP ANI Pharmaceuticals | $63.18
+2.0% | 5/12/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $86.00 -> $86.00 | High | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 5/12/2025 |
KYMR Kymera Therapeutics | $47.16
-1.0% | 5/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $52.00 -> $52.00 | Low | View details for Guggenheim rating of Kymera Therapeutics (NASDAQ:KYMR) on 5/12/2025 |
QURE uniQure | $16.90
-2.1% | 5/12/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $28.00 -> $28.00 | Low | View details for Guggenheim rating of uniQure (NASDAQ:QURE) on 5/12/2025 |
SPOT Spotify Technology | $699.13
-1.8% | 5/12/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $675.00 -> $725.00 | Low | View details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 5/12/2025 |
NTLA Intellia Therapeutics | $8.28
+2.3% | 5/12/2025 | Target Lowered by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $55.00 -> $45.00 | Medium | View details for Guggenheim rating of Intellia Therapeutics (NASDAQ:NTLA) on 5/12/2025 |
DKNG DraftKings | $36.20
+1.1% | 5/12/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $61.00 -> $60.00 | Low | View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 5/12/2025 |
WMG Warner Music Group | $26.21
-0.6% | 5/9/2025 | Target Lowered by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $40.00 -> $37.00 | Low | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 5/9/2025 |
ARDT Ardent Health Partners | $13.63
-8.3% | 5/9/2025 | Target Raised by | Guggenheim | Analyst J. Cassorla | Buy -> Buy | $16.00 -> $18.00 | Low | View details for Guggenheim rating of Ardent Health Partners (NYSE:ARDT) on 5/9/2025 |
ARGX argenx | $583.62
-0.4% | 5/9/2025 | Target Lowered by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $1,100.00 -> $1,065.00 | Low | View details for Guggenheim rating of argenx (NASDAQ:ARGX) on 5/9/2025 |
GHRS GH Research | $13.70
+9.6% | 5/9/2025 | Target Lowered by | Guggenheim | Analyst E. Hickman | Buy -> Buy | $32.00 -> $29.00 | Medium | View details for Guggenheim rating of GH Research (NASDAQ:GHRS) on 5/9/2025 |
SPHR Sphere Entertainment | $38.42
+2.0% | 5/9/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $69.00 -> $74.00 | Medium | View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 5/9/2025 |
EPAM EPAM Systems | $176.75
-0.8% | 5/9/2025 | Target Raised by | Guggenheim | Analyst Jonathan Lee | Buy -> Buy | $210.00 -> $215.00 | Low | View details for Guggenheim rating of EPAM Systems (NYSE:EPAM) on 5/9/2025 |
PINS Pinterest | $34.17
-0.1% | 5/9/2025 | Target Lowered by | Guggenheim | Analyst M. Morris | Buy -> Buy | $40.00 -> $39.00 | Low | View details for Guggenheim rating of Pinterest (NYSE:PINS) on 5/9/2025 |
WING Wingstop | $376.13
+0.3% | 5/9/2025 | Target Raised by | Guggenheim | Analyst G. Francfort | Buy -> Buy | $280.00 -> $325.00 | Low | View details for Guggenheim rating of Wingstop (NASDAQ:WING) on 5/9/2025 |
ILMN Illumina | $84.98
+2.8% | 5/9/2025 | Target Lowered by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $122.00 -> $114.00 | Medium | View details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 5/9/2025 |
ARHS Arhaus | $8.83
+0.8% | 5/9/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $14.00 -> $12.00 | High | View details for Guggenheim rating of Arhaus (NASDAQ:ARHS) on 5/9/2025 |
TKO TKO Group | $163.42
-1.5% | 5/9/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $175.00 -> $190.00 | High | View details for Guggenheim rating of TKO Group (NYSE:TKO) on 5/9/2025 |
SN SharkNinja | $87.89
+0.7% | 5/9/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $135.00 -> $120.00 | Medium | View details for Guggenheim rating of SharkNinja (NYSE:SN) on 5/9/2025 |
SHLS Shoals Technologies Group | $5.10
-1.2% | 5/9/2025 | Target Raised by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $5.00 -> $6.00 | High | View details for Guggenheim rating of Shoals Technologies Group (NASDAQ:SHLS) on 5/9/2025 |
CDTX Cidara Therapeutics | $25.38
+0.6% | 5/9/2025 | Target Raised by | Guggenheim | Analyst S. Fernandez | Buy -> Buy | $33.00 -> $35.00 | High | View details for Guggenheim rating of Cidara Therapeutics (NASDAQ:CDTX) on 5/9/2025 |
CMPX Compass Therapeutics | $2.57
+2.8% | 5/9/2025 | Target Lowered by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $12.00 -> $10.00 | High | View details for Guggenheim rating of Compass Therapeutics (NASDAQ:CMPX) on 5/9/2025 |
NET Cloudflare | $177.95
-1.0% | 5/9/2025 | Target Raised by | Guggenheim | Analyst John Difucci | Sell -> Sell | $68.00 -> $70.00 | Medium | View details for Guggenheim rating of Cloudflare (NYSE:NET) on 5/9/2025 |
TTD Trade Desk | $71.49
+0.0% | 5/9/2025 | Target Lowered by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $110.00 -> $90.00 | High | View details for Guggenheim rating of Trade Desk (NASDAQ:TTD) on 5/9/2025 |
ONC Beigene | $263.78
+3.1% | 5/8/2025 | Target Raised by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $348.00 -> $350.00 | Medium | View details for Guggenheim rating of Beigene (NASDAQ:ONC) on 5/8/2025 |
NI NiSource | $39.34
+0.1% | 5/8/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $42.00 -> $43.00 | Low | View details for Guggenheim rating of NiSource (NYSE:NI) on 5/8/2025 |
NYT New York Times | $55.67
-0.3% | 5/8/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Neutral -> Neutral | $52.00 -> $53.00 | Low | View details for Guggenheim rating of New York Times (NYSE:NYT) on 5/8/2025 |
RVMD Revolution Medicines | $40.58
-1.2% | 5/8/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $87.00 -> $80.00 | Low | View details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 5/8/2025 |
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad) Something big is brewing in Washington.
According to my research, an executive order from President Trump could be just weeks away.
And it holds the potential to trigger one of the most explosive tech booms in US history.
At the center of it all? Robots.
Not the kind that clean your house or pour you coffee.
But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year. This little-known company holds nearly 100 patents and trades for around $7 |
ARM ARM | $138.61
+4.1% | 5/8/2025 | Target Lowered by | Guggenheim | Analyst John Difucci | Buy -> Buy | $180.00 -> $147.00 | High | View details for Guggenheim rating of ARM (NASDAQ:ARM) on 5/8/2025 |
DIS Walt Disney | $115.72
+1.6% | 5/8/2025 | Target Lowered by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $130.00 -> $120.00 | Low | View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 5/8/2025 |
SLNO Soleno Therapeutics | $77.73
+2.9% | 5/8/2025 | Target Raised by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $81.00 -> $97.00 | High | View details for Guggenheim rating of Soleno Therapeutics (NASDAQ:SLNO) on 5/8/2025 |
FWRG First Watch Restaurant Group | $15.97
+7.0% | 5/8/2025 | Target Lowered by | Guggenheim | Analyst Gregory Francfort | Buy -> Buy | $23.00 -> $22.00 | Low | View details for Guggenheim rating of First Watch Restaurant Group (NASDAQ:FWRG) on 5/8/2025 |
DG Dollar General | $113.32
-0.1% | 5/8/2025 | Target Raised by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $100.00 -> $105.00 | Low | View details for Guggenheim rating of Dollar General (NYSE:DG) on 5/8/2025 |
VALN Valneva | $6.08
-1.3% | 5/8/2025 | Target Lowered by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $15.00 -> $14.00 | Low | View details for Guggenheim rating of Valneva (NASDAQ:VALN) on 5/8/2025 |
OGS ONE Gas | $73.61
+0.2% | 5/7/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $69.00 -> $73.00 | Low | View details for Guggenheim rating of ONE Gas (NYSE:OGS) on 5/7/2025 |
SRPT Sarepta Therapeutics | $39.71
-7.7% | 5/7/2025 | Target Lowered by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $112.00 -> $98.00 | High | View details for Guggenheim rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/7/2025 |
TDC Teradata | $22.59
+0.9% | 5/7/2025 | Target Lowered by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $37.00 -> $35.00 | High | View details for Guggenheim rating of Teradata (NYSE:TDC) on 5/7/2025 |
RLAY Relay Therapeutics | $3.36
| 5/7/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $30.00 -> $10.00 | High | View details for Guggenheim rating of Relay Therapeutics (NASDAQ:RLAY) on 5/7/2025 |
AEP American Electric Power | $101.41
-0.4% | 5/7/2025 | Target Raised by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $109.00 -> $115.00 | Low | View details for Guggenheim rating of American Electric Power (NASDAQ:AEP) on 5/7/2025 |
BEAM Beam Therapeutics | $18.17
-2.2% | 5/7/2025 | Target Lowered by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $78.00 -> $55.00 | High | View details for Guggenheim rating of Beam Therapeutics (NASDAQ:BEAM) on 5/7/2025 |
KRYS Krystal Biotech | $136.08
-0.6% | 5/7/2025 | Target Lowered by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $195.00 -> $189.00 | Low | View details for Guggenheim rating of Krystal Biotech (NASDAQ:KRYS) on 5/7/2025 |
TWST Twist Bioscience | $33.36
+5.7% | 5/6/2025 | Reiterated by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $50.00 -> $50.00 | High | View details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 5/6/2025 |
NBIX Neurocrine Biosciences | $125.73
+0.3% | 5/6/2025 | Target Raised by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $155.00 -> $165.00 | High | View details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/6/2025 |
ANAB AnaptysBio | $23.19
-2.2% | 5/6/2025 | Target Raised by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $52.00 -> $54.00 | High | View details for Guggenheim rating of AnaptysBio (NASDAQ:ANAB) on 5/6/2025 |
SNDX Syndax Pharmaceuticals | $11.09
-3.1% | 5/6/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $32.00 -> $32.00 | High | View details for Guggenheim rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 5/6/2025 |
RIVN Rivian Automotive | $14.40
+2.9% | 5/6/2025 | Reiterated by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $16.00 -> $16.00 | Low | View details for Guggenheim rating of Rivian Automotive (NASDAQ:RIVN) on 5/6/2025 |
MSGS Madison Square Garden Sports | $189.72
-0.8% | 5/6/2025 | Reiterated by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $314.00 -> $314.00 | Low | View details for Guggenheim rating of Madison Square Garden Sports (NYSE:MSGS) on 5/6/2025 |
MTZ MasTec | $162.66
-0.6% | 5/5/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $195.00 -> $195.00 | Low | View details for Guggenheim rating of MasTec (NYSE:MTZ) on 5/5/2025 |
CI The Cigna Group | $311.33
-0.3% | 5/5/2025 | Reiterated by | Guggenheim | Analyst J. Cassorla | Buy -> Buy | $384.00 -> $388.00 | Low | View details for Guggenheim rating of The Cigna Group (NYSE:CI) on 5/5/2025 |
DLTR Dollar Tree | $93.85
-0.7% | 5/5/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $95.00 -> $100.00 | Low | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 5/5/2025 |
ARVN Arvinas | $7.83
+4.0% | 5/2/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $32.00 -> $16.00 | High | View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 5/2/2025 |
FND Floor & Decor | $74.80
+4.7% | 5/2/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $115.00 -> $100.00 | High | View details for Guggenheim rating of Floor & Decor (NYSE:FND) on 5/2/2025 |
TARS Tarsus Pharmaceuticals | $43.11
-1.8% | 5/2/2025 | Target Raised by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | $78.00 -> $84.00 | High | View details for Guggenheim rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 5/2/2025 |
RDDT Reddit | $117.65
-3.0% | 5/2/2025 | Target Lowered by | Guggenheim | Analyst M. Morris | Buy -> Buy | $170.00 -> $165.00 | High | View details for Guggenheim rating of Reddit (NYSE:RDDT) on 5/2/2025 |
ED Consolidated Edison | $101.11
-0.5% | 5/2/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $96.00 -> $103.00 | Low | View details for Guggenheim rating of Consolidated Edison (NYSE:ED) on 5/2/2025 |
IDA IDACORP | $115.74
+0.5% | 5/2/2025 | Target Raised by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $121.00 -> $126.00 | Low | View details for Guggenheim rating of IDACORP (NYSE:IDA) on 5/2/2025 |
EXC Exelon | $42.20
-1.0% | 5/2/2025 | Target Raised by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $47.00 -> $50.00 | Low | View details for Guggenheim rating of Exelon (NASDAQ:EXC) on 5/2/2025 |
PHAT Phathom Pharmaceuticals | $8.83
-1.0% | 5/2/2025 | Target Lowered by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $18.00 -> $12.00 | Low | View details for Guggenheim rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 5/2/2025 |
ROKU Roku | $79.59
+1.4% | 5/2/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $100.00 -> $100.00 | High | View details for Guggenheim rating of Roku (NASDAQ:ROKU) on 5/2/2025 |
SO Southern | $88.51
+0.3% | 5/2/2025 | Reiterated by | Guggenheim | Analyst S. Pourreza | Neutral -> Neutral | $93.00 -> $93.00 | Low | View details for Guggenheim rating of Southern (NYSE:SO) on 5/2/2025 |
W Wayfair | $47.41
+4.7% | 5/2/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $60.00 -> $50.00 | Low | View details for Guggenheim rating of Wayfair (NYSE:W) on 5/2/2025 |
IONS Ionis Pharmaceuticals | $36.76
+4.2% | 5/1/2025 | Target Lowered by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $65.00 -> $64.00 | Medium | View details for Guggenheim rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 5/1/2025 |
PEG Public Service Enterprise Group | $79.62
-0.7% | 5/1/2025 | Target Lowered by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $98.00 -> $94.00 | High | View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 5/1/2025 |
REGN Regeneron Pharmaceuticals | $517.60
+4.9% | 5/1/2025 | Target Lowered by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $940.00 -> $810.00 | Low | View details for Guggenheim rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 5/1/2025 |
FSLR First Solar | $160.16
-3.7% | 5/1/2025 | Target Lowered by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $253.00 -> $202.00 | Medium | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 5/1/2025 |
MSFT Microsoft | $472.75
+0.5% | 5/1/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | High | View details for Guggenheim rating of Microsoft (NASDAQ:MSFT) on 5/1/2025 |
CFLT Confluent | $24.39
+0.1% | 5/1/2025 | Target Lowered by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $38.00 -> $31.00 | High | View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 5/1/2025 |
PPL PPL | $33.93
-0.3% | 5/1/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $38.00 -> $40.00 | Low | View details for Guggenheim rating of PPL (NYSE:PPL) on 5/1/2025 |
META Meta Platforms | $694.06
-0.5% | 5/1/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $675.00 -> $725.00 | High | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 5/1/2025 |
LLY Eli Lilly and Company | $773.59
+0.5% | 5/1/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | High | View details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 5/1/2025 |
EWTX Edgewise Therapeutics | $15.26
+0.1% | 4/30/2025 | Initiated by | Guggenheim | Analyst D. Chattopadhyay | Buy | $41.00 | High | View details for Guggenheim rating of Edgewise Therapeutics (NASDAQ:EWTX) on 4/30/2025 |
CNC Centene | $55.71
+1.0% | 4/29/2025 | Reiterated by | Guggenheim | Analyst J. Cassorla | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Centene (NYSE:CNC) on 4/29/2025 |
URGN UroGen Pharma | $7.02
-4.7% | 4/29/2025 | Reiterated by | Guggenheim | Analyst Kelsey Goodwin | Buy -> Buy | | High | View details for Guggenheim rating of UroGen Pharma (NASDAQ:URGN) on 4/29/2025 |
SBUX Starbucks | $90.67
+1.1% | 4/29/2025 | Target Lowered by | Guggenheim | Analyst Gregory Francfort | Neutral -> Neutral | $95.00 -> $83.00 | Medium | View details for Guggenheim rating of Starbucks (NASDAQ:SBUX) on 4/29/2025 |
ABBV AbbVie | $189.13
-0.4% | 4/29/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $214.00 -> $216.00 | Low | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 4/29/2025 |
CMG Chipotle Mexican Grill | $51.15
-2.6% | 4/25/2025 | Target Set by | Guggenheim | - | | $47.00 | Low | View details for Guggenheim rating of Chipotle Mexican Grill (NYSE:CMG) on 4/25/2025 |
SWTX SpringWorks Therapeutics | $46.75
-0.1% | 4/28/2025 | Downgraded by | Guggenheim | Analyst Michael Schmidt | Buy -> Neutral | $77.00 -> $47.00 | Low | View details for Guggenheim rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 4/28/2025 |
PCG PG&E | $14.58
-6.8% | 4/25/2025 | Target Raised by | Guggenheim | Analyst S. Pourreza | Neutral -> Neutral | $16.00 -> $17.00 | Low | View details for Guggenheim rating of PG&E (NYSE:PCG) on 4/25/2025 |
Elon’s NEXT Big IPO? (Ad) Cancel your internet TODAY!?
Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up.
It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry.
But you may only have this chance if you act before December 31st, 2025. One that experts predict could be worth over $3.2 TRILLION globally by 2030. |
TSCO Tractor Supply | $50.51
-0.8% | 4/25/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $60.00 -> $55.00 | Low | View details for Guggenheim rating of Tractor Supply (NASDAQ:TSCO) on 4/25/2025 |
EPAM EPAM Systems | $176.75
-0.8% | 4/25/2025 | Target Lowered by | Guggenheim | Analyst Jonathan Lee | Buy -> Buy | $285.00 -> $210.00 | Low | View details for Guggenheim rating of EPAM Systems (NYSE:EPAM) on 4/25/2025 |
AEE Ameren | $95.91
-0.1% | 4/22/2025 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | Low | View details for Guggenheim rating of Ameren (NYSE:AEE) on 4/22/2025 |
EXC Exelon | $42.20
-1.0% | 4/22/2025 | Target Set by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $47.00 | Low | View details for Guggenheim rating of Exelon (NASDAQ:EXC) on 4/22/2025 |
TSLA Tesla | $308.58
+4.6% | 4/24/2025 | Reiterated by | Guggenheim | Analyst Ronald Jewsikow | Sell -> Sell | $170.00 -> $170.00 | Medium | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 4/24/2025 |
NOW ServiceNow | $1,027.05
-0.3% | 4/24/2025 | Target Raised by | Guggenheim | Analyst John Difucci | Sell -> Sell | $716.00 -> $724.00 | Low | View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 4/24/2025 |
GEV GE Vernova | $480.39
-1.0% | 4/24/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $380.00 -> $380.00 | Low | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 4/24/2025 |
MSFT Microsoft | $472.75
+0.5% | 4/23/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Microsoft (NASDAQ:MSFT) on 4/23/2025 |
ELV Elevance Health | $389.66
-0.9% | 4/23/2025 | Reiterated by | Guggenheim | Analyst J. Cassorla | Buy -> Buy | $518.00 -> $518.00 | Low | View details for Guggenheim rating of Elevance Health (NYSE:ELV) on 4/23/2025 |
CTSH Cognizant Technology Solutions | $80.47
+0.2% | 4/23/2025 | Reiterated by | Guggenheim | Analyst Jonathan Lee | Neutral -> Neutral | | Low | View details for Guggenheim rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 4/23/2025 |
DHR Danaher | $199.26
+1.7% | 4/23/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | $250.00 -> $250.00 | Medium | View details for Guggenheim rating of Danaher (NYSE:DHR) on 4/23/2025 |
SPHR Sphere Entertainment | $38.42
+2.0% | 4/23/2025 | Reiterated by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $69.00 -> $69.00 | Low | View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 4/23/2025 |
TKO TKO Group | $163.42
-1.5% | 4/23/2025 | Reiterated by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $175.00 -> $175.00 | Low | View details for Guggenheim rating of TKO Group (NYSE:TKO) on 4/23/2025 |
CVLT Commvault Systems | $190.99
+1.3% | 4/23/2025 | Reiterated by | Guggenheim | Analyst Howard Ma | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Commvault Systems (NASDAQ:CVLT) on 4/23/2025 |
CFLT Confluent | $24.39
+0.1% | 4/23/2025 | Reiterated by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $38.00 -> $38.00 | Low | View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 4/23/2025 |
SEDG SolarEdge Technologies | $18.72
+2.9% | 4/23/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Neutral -> Sell | $5.00 | High | View details for Guggenheim rating of SolarEdge Technologies (NASDAQ:SEDG) on 4/23/2025 |
ENPH Enphase Energy | $43.26
+5.1% | 4/23/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Neutral -> Sell | $33.00 | High | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 4/23/2025 |
NVO Novo Nordisk A/S | $75.45
+1.1% | 4/17/2025 | Downgraded by | Guggenheim | Analyst S. Fernandez | Strong-Buy -> Hold | | Low | View details for Guggenheim rating of Novo Nordisk A/S (NYSE:NVO) on 4/17/2025 |
CMG Chipotle Mexican Grill | $51.15
-2.6% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Gregory Francfort | Neutral -> Neutral | $56.00 -> $48.00 | Low | View details for Guggenheim rating of Chipotle Mexican Grill (NYSE:CMG) on 4/22/2025 |
DPZ Domino's Pizza | $467.95
-0.1% | 4/22/2025 | Target Raised by | Guggenheim | Analyst Gregory Francfort | Neutral -> Neutral | $450.00 -> $460.00 | High | View details for Guggenheim rating of Domino’s Pizza (NASDAQ:DPZ) on 4/22/2025 |
CMPX Compass Therapeutics | $2.57
+2.8% | 4/22/2025 | Reiterated by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | | High | View details for Guggenheim rating of Compass Therapeutics (NASDAQ:CMPX) on 4/22/2025 |
VC Visteon | $84.53
+1.2% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $108.00 -> $91.00 | Low | View details for Guggenheim rating of Visteon (NASDAQ:VC) on 4/22/2025 |
LAD Lithia Motors | $323.44
+0.7% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $417.00 -> $356.00 | Medium | View details for Guggenheim rating of Lithia Motors (NYSE:LAD) on 4/22/2025 |
GPI Group 1 Automotive | $431.26
+2.0% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $502.00 -> $426.00 | High | View details for Guggenheim rating of Group 1 Automotive (NYSE:GPI) on 4/22/2025 |
GNTX Gentex | $21.64
+1.1% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $30.00 -> $24.00 | Low | View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 4/22/2025 |
BWA BorgWarner | $32.63
+1.0% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $38.00 -> $33.00 | Low | View details for Guggenheim rating of BorgWarner (NYSE:BWA) on 4/22/2025 |
APTV Aptiv | $67.20
+0.8% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $75.00 -> $64.00 | Low | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 4/22/2025 |
AN AutoNation | $189.17
+1.1% | 4/22/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $212.00 -> $183.00 | Low | View details for Guggenheim rating of AutoNation (NYSE:AN) on 4/22/2025 |
CRM Salesforce | $272.36
-0.8% | 4/21/2025 | Upgraded by | Guggenheim | Analyst J. Difucci | Sell -> Neutral | | Medium | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 4/21/2025 |
UNCY Unicycive Therapeutics | $0.90
+19.3% | 4/21/2025 | Initiated by | Guggenheim | Analyst Vamil Divan | Buy | $6.00 | High | View details for Guggenheim rating of Unicycive Therapeutics (NASDAQ:UNCY) on 4/21/2025 |
NFLX Netflix | $1,224.46
-1.4% | 4/18/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $1,100.00 -> $1,150.00 | N/A | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 4/18/2025 |
MRK Merck & Co., Inc. | $79.30
+0.4% | 4/17/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $115.00 -> $115.00 | Low | View details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 4/17/2025 |
GEV GE Vernova | $480.39
-1.0% | 4/17/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $380.00 -> $380.00 | Low | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 4/17/2025 |
ITRI Itron | $121.58
+0.8% | 4/17/2025 | Reiterated by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $133.00 -> $133.00 | Low | View details for Guggenheim rating of Itron (NASDAQ:ITRI) on 4/17/2025 |
ABBV AbbVie | $189.13
-0.4% | 4/17/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $214.00 -> $214.00 | Low | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 4/17/2025 |
NOW ServiceNow | $1,027.05
-0.3% | 4/16/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Sell -> Sell | $716.00 -> $716.00 | High | View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 4/16/2025 |
CYRX Cryoport | $6.96
-0.6% | 4/16/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for Guggenheim rating of Cryoport (NASDAQ:CYRX) on 4/16/2025 |
ONC Beigene | $263.78
+3.1% | 4/16/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | Medium | View details for Guggenheim rating of Beigene (NASDAQ:ONC) on 4/16/2025 |
VERV Verve Therapeutics | $6.10
-1.6% | 4/15/2025 | Target Raised by | Guggenheim | Analyst Etzer Darout | Buy -> Buy | $18.00 -> $24.00 | High | View details for Guggenheim rating of Verve Therapeutics (NASDAQ:VERV) on 4/15/2025 |
FLNC Fluence Energy | $4.76
+0.8% | 4/15/2025 | Target Lowered by | Guggenheim | Analyst J. Osha | Sell -> Sell | $6.00 -> $2.00 | High | View details for Guggenheim rating of Fluence Energy (NASDAQ:FLNC) on 4/15/2025 |
LLY Eli Lilly and Company | $773.59
+0.5% | 4/14/2025 | Target Lowered by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | $973.00 -> $928.00 | Low | View details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 4/14/2025 |
PLNT Planet Fitness | $102.60
-2.8% | 4/14/2025 | Target Raised by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $105.00 -> $110.00 | Low | View details for Guggenheim rating of Planet Fitness (NYSE:PLNT) on 4/14/2025 |
USFD US Foods | $76.94
-1.0% | 4/14/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $80.00 -> $80.00 | Low | View details for Guggenheim rating of US Foods (NYSE:USFD) on 4/14/2025 |
TVTX Travere Therapeutics | $14.91
-2.7% | 4/14/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $47.00 -> $47.00 | Low | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 4/14/2025 |
EXAS Exact Sciences | $54.63
-0.4% | 4/11/2025 | Reiterated by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $60.00 -> $60.00 | High | View details for Guggenheim rating of Exact Sciences (NASDAQ:EXAS) on 4/11/2025 |
TGNA TEGNA | $16.56
+0.9% | 4/11/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $22.00 -> $20.00 | Low | View details for Guggenheim rating of TEGNA (NYSE:TGNA) on 4/11/2025 |
ANIP ANI Pharmaceuticals | $63.18
+2.0% | 4/11/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $86.00 -> $86.00 | High | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 4/11/2025 |
ONC Beigene | $263.78
+3.1% | 4/10/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $348.00 -> $348.00 | High | View details for Guggenheim rating of Beigene (NASDAQ:ONC) on 4/10/2025 |
PRIM Primoris Services | $73.87
-2.7% | 4/10/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $110.00 -> $110.00 | Low | View details for Guggenheim rating of Primoris Services (NASDAQ:PRIM) on 4/10/2025 |
MBX MBX Biosciences | $11.36
-0.1% | 4/10/2025 | Reiterated by | Guggenheim | Analyst S. Fernandez | Buy -> Buy | $44.00 -> $44.00 | Medium | View details for Guggenheim rating of MBX Biosciences (NYSE:MBX) on 4/10/2025 |
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad) Something big is brewing in Washington.
According to my research, an executive order from President Trump could be just weeks away.
And it holds the potential to trigger one of the most explosive tech booms in US history.
At the center of it all? Robots.
Not the kind that clean your house or pour you coffee.
But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year. This little-known company holds nearly 100 patents and trades for around $7 |
DKNG DraftKings | $36.20
+1.1% | 4/10/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $62.00 -> $61.00 | Low | View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 4/10/2025 |
NEOG Neogen | $5.52
+6.0% | 4/10/2025 | Target Lowered by | Guggenheim | Analyst S. Nambi | Buy -> Buy | $15.00 -> $13.00 | High | View details for Guggenheim rating of Neogen (NASDAQ:NEOG) on 4/10/2025 |
ACHC Acadia Healthcare | $21.99
-3.3% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $36.00 | High | View details for Guggenheim rating of Acadia Healthcare (NASDAQ:ACHC) on 4/9/2025 |
CI The Cigna Group | $311.33
-0.3% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $384.00 | High | View details for Guggenheim rating of The Cigna Group (NYSE:CI) on 4/9/2025 |
HUM Humana | $233.04
+1.0% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $326.00 | High | View details for Guggenheim rating of Humana (NYSE:HUM) on 4/9/2025 |
HCA HCA Healthcare | $373.18
-2.9% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Neutral | | High | View details for Guggenheim rating of HCA Healthcare (NYSE:HCA) on 4/9/2025 |
CYH Community Health Systems | $3.45
-11.9% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Neutral | | High | View details for Guggenheim rating of Community Health Systems (NYSE:CYH) on 4/9/2025 |
UHS Universal Health Services | $177.81
-6.1% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $208.00 | High | View details for Guggenheim rating of Universal Health Services (NYSE:UHS) on 4/9/2025 |
THC Tenet Healthcare | $166.25
-3.0% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $165.00 | High | View details for Guggenheim rating of Tenet Healthcare (NYSE:THC) on 4/9/2025 |
MOH Molina Healthcare | $296.87
0.0% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Neutral | | Medium | View details for Guggenheim rating of Molina Healthcare (NYSE:MOH) on 4/9/2025 |
CNC Centene | $55.71
+1.0% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Neutral | | Medium | View details for Guggenheim rating of Centene (NYSE:CNC) on 4/9/2025 |
ELV Elevance Health | $389.66
-0.9% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $518.00 | High | View details for Guggenheim rating of Elevance Health (NYSE:ELV) on 4/9/2025 |
VCYT Veracyte | $27.85
+1.4% | 4/9/2025 | Target Lowered by | Guggenheim | Analyst S. Nambi | Buy -> Buy | $45.00 -> $37.00 | High | View details for Guggenheim rating of Veracyte (NASDAQ:VCYT) on 4/9/2025 |
ARDT Ardent Health Partners | $13.63
-8.3% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $16.00 | High | View details for Guggenheim rating of Ardent Health Partners (NYSE:ARDT) on 4/9/2025 |
MYGN Myriad Genetics | $5.19
+2.0% | 4/9/2025 | Downgraded by | Guggenheim | Analyst Subbu Nambi | Buy -> Neutral | | High | View details for Guggenheim rating of Myriad Genetics (NASDAQ:MYGN) on 4/9/2025 |
META Meta Platforms | $694.06
-0.5% | 4/8/2025 | Target Lowered by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $750.00 -> $675.00 | Medium | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 4/8/2025 |
YUM Yum! Brands | $143.12
-1.2% | 4/8/2025 | Target Raised by | Guggenheim | Analyst Gregory Francfort | Buy -> Buy | $155.00 -> $165.00 | High | View details for Guggenheim rating of Yum! Brands (NYSE:YUM) on 4/8/2025 |
FE FirstEnergy | $39.79
-2.1% | 4/7/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $45.00 -> $47.00 | Low | View details for Guggenheim rating of FirstEnergy (NYSE:FE) on 4/7/2025 |
FSLR First Solar | $160.16
-3.7% | 4/7/2025 | Target Lowered by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $304.00 -> $253.00 | Medium | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 4/7/2025 |
IVA Inventiva | $3.63
+0.4% | 4/4/2025 | Target Lowered by | Guggenheim | Analyst Etzer Darout | Buy -> Buy | $12.00 -> $9.00 | High | View details for Guggenheim rating of Inventiva (NASDAQ:IVA) on 4/4/2025 |
QSR Restaurant Brands International | $69.78
-2.1% | 4/4/2025 | Target Raised by | Guggenheim | Analyst G. Francfort | Buy -> Buy | $71.00 -> $77.00 | High | View details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 4/4/2025 |
NBTX Nanobiotix | $4.69
-0.5% | 4/4/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $12.00 -> $8.00 | Low | View details for Guggenheim rating of Nanobiotix (NASDAQ:NBTX) on 4/4/2025 |
IONS Ionis Pharmaceuticals | $36.76
+4.2% | 4/3/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | | High | View details for Guggenheim rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/3/2025 |
ARQT Arcutis Biotherapeutics | $14.21
-1.1% | 4/3/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | Medium | View details for Guggenheim rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 4/3/2025 |
RH RH | $184.85
+0.7% | 4/3/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $500.00 -> $300.00 | High | View details for Guggenheim rating of RH (NYSE:RH) on 4/3/2025 |
KR Kroger | $65.47
-1.0% | 4/3/2025 | Target Raised by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $71.00 -> $73.00 | High | View details for Guggenheim rating of Kroger (NYSE:KR) on 4/3/2025 |
NFLX Netflix | $1,224.46
-1.4% | 4/3/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $1,100.00 -> $1,100.00 | Low | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 4/3/2025 |
SRAD Sportradar Group | $24.12
+0.1% | 4/3/2025 | Reiterated by | Guggenheim | Analyst C. Baker | Buy -> Buy | $27.00 -> $27.00 | Low | View details for Guggenheim rating of Sportradar Group (NASDAQ:SRAD) on 4/3/2025 |
ORCL Oracle | $177.19
+1.8% | 4/3/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $220.00 -> $220.00 | Low | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 4/3/2025 |
TWST Twist Bioscience | $33.36
+5.7% | 3/28/2025 | Target Set by | Guggenheim | - | | $50.00 | High | View details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 3/28/2025 |
CMPX Compass Therapeutics | $2.57
+2.8% | 4/2/2025 | Reiterated by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $12.00 -> $12.00 | High | View details for Guggenheim rating of Compass Therapeutics (NASDAQ:CMPX) on 4/2/2025 |
MAZE Maze Therapeutics | $12.81
-0.9% | 4/2/2025 | Reiterated by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | $19.00 -> $19.00 | Medium | View details for Guggenheim rating of Maze Therapeutics (NASDAQ:MAZE) on 4/2/2025 |
SNAP Snap | $8.52
+3.0% | 4/2/2025 | Reiterated by | Guggenheim | Analyst M. Morris | Neutral -> Neutral | | Low | View details for Guggenheim rating of Snap (NYSE:SNAP) on 4/2/2025 |
PHAT Phathom Pharmaceuticals | $8.83
-1.0% | 4/2/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | | High | View details for Guggenheim rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 4/2/2025 |
JNJ Johnson & Johnson | $155.19
+0.1% | 4/2/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Neutral -> Neutral | | Low | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 4/2/2025 |
PINS Pinterest | $34.17
-0.1% | 4/1/2025 | Reiterated by | Guggenheim | Analyst M. Morris | Buy -> Buy | | Low | View details for Guggenheim rating of Pinterest (NYSE:PINS) on 4/1/2025 |
SR Spire | $73.88
+0.3% | 4/1/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $67.00 -> $72.00 | Medium | View details for Guggenheim rating of Spire (NYSE:SR) on 4/1/2025 |
PRGS Progress Software | $64.28
+0.2% | 4/1/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $83.00 -> $83.00 | High | View details for Guggenheim rating of Progress Software (NASDAQ:PRGS) on 4/1/2025 |
PMN ProMIS Neurosciences | $0.51
+5.6% | 4/1/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | $6.00 -> $6.00 | High | View details for Guggenheim rating of ProMIS Neurosciences (NASDAQ:PMN) on 4/1/2025 |
CABA Cabaletta Bio | $2.37
-4.4% | 4/1/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $23.00 -> $23.00 | High | View details for Guggenheim rating of Cabaletta Bio (NASDAQ:CABA) on 4/1/2025 |
ADCT ADC Therapeutics | $3.57
-2.7% | 3/31/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $10.00 -> $7.00 | High | View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 3/31/2025 |
BROS Dutch Bros | $73.36
+0.4% | 3/31/2025 | Target Raised by | Guggenheim | Analyst Gregory Francfort | Buy -> Buy | $54.00 -> $72.00 | Medium | View details for Guggenheim rating of Dutch Bros (NYSE:BROS) on 3/31/2025 |
DLTR Dollar Tree | $93.85
-0.7% | 3/28/2025 | Target Lowered by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $100.00 -> $95.00 | Medium | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 3/28/2025 |
MRUS Merus | $54.91
-2.3% | 3/28/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $109.00 -> $109.00 | Low | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 3/28/2025 |
IPSC Century Therapeutics | $0.63
+1.7% | 3/28/2025 | Reiterated by | Guggenheim | Analyst Kelsey Goodwin | Buy -> Buy | | High | View details for Guggenheim rating of Century Therapeutics (NASDAQ:IPSC) on 3/28/2025 |
SLNO Soleno Therapeutics | $77.73
+2.9% | 3/28/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $70.00 -> $81.00 | High | View details for Guggenheim rating of Soleno Therapeutics (NASDAQ:SLNO) on 3/28/2025 |
CSTL Castle Biosciences | $18.17
+3.2% | 3/28/2025 | Target Set by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $30.00 | High | View details for Guggenheim rating of Castle Biosciences (NASDAQ:CSTL) on 3/28/2025 |
EXAS Exact Sciences | $54.63
-0.4% | 3/28/2025 | Target Set by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $60.00 | High | View details for Guggenheim rating of Exact Sciences (NASDAQ:EXAS) on 3/28/2025 |
CNTA Centessa Pharmaceuticals | $11.94
+0.2% | 3/26/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $28.00 -> $28.00 | High | View details for Guggenheim rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 3/26/2025 |
RH RH | $184.85
+0.7% | 3/26/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $550.00 -> $500.00 | Medium | View details for Guggenheim rating of RH (NYSE:RH) on 3/26/2025 |
IFRX InflaRx | $0.85
+2.4% | 3/26/2025 | Target Raised by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $7.00 -> $10.00 | High | View details for Guggenheim rating of InflaRx (NASDAQ:IFRX) on 3/26/2025 |
ADAP Adaptimmune Therapeutics | $0.28
-0.5% | 3/26/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $3.00 -> $1.75 | High | View details for Guggenheim rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 3/26/2025 |
ZURA Zura Bio | $1.25
-0.8% | 3/26/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for Guggenheim rating of Zura Bio (NASDAQ:ZURA) on 3/26/2025 |
MTZ MasTec | $162.66
-0.6% | 3/25/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $195.00 -> $195.00 | Low | View details for Guggenheim rating of MasTec (NYSE:MTZ) on 3/25/2025 |
FOXA FOX | $54.10
-0.5% | 3/25/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $60.00 -> $60.00 | Medium | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 3/25/2025 |
LRMR Larimar Therapeutics | $2.66
-0.7% | 3/25/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $26.00 -> $26.00 | Medium | View details for Guggenheim rating of Larimar Therapeutics (NASDAQ:LRMR) on 3/25/2025 |
VERV Verve Therapeutics | $6.10
-1.6% | 3/25/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | High | View details for Guggenheim rating of Verve Therapeutics (NASDAQ:VERV) on 3/25/2025 |
ASMB Assembly Biosciences | $16.07
-1.0% | 3/25/2025 | Initiated by | Guggenheim | Analyst Vamil Divan | Buy | $31.00 | Low | View details for Guggenheim rating of Assembly Biosciences (NASDAQ:ASMB) on 3/25/2025 |
DRI Darden Restaurants | $219.75
+1.0% | 3/24/2025 | Target Raised by | Guggenheim | Analyst Greg Francfort | Buy -> Buy | $205.00 -> $220.00 | High | View details for Guggenheim rating of Darden Restaurants (NYSE:DRI) on 3/24/2025 |
VSTM Verastem | $6.11
-4.8% | 3/24/2025 | Target Raised by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $13.00 -> $14.00 | Medium | View details for Guggenheim rating of Verastem (NASDAQ:VSTM) on 3/24/2025 |
